Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech products for the global market. The company is committed to improving patient welfare and outcomes, increase clinical data accuracy and promoting positive health economics.
Observe Medical is building a scalable Nordic medtech platform — combining a portfolio of proprietary products and innovation with partnerships that leverage our manufacturing, development, regulatory, and commercial capabilities to bring new technologies to market.
Reference is made to Observe Medical ASA's Interim Report H1 2026 published on August 25, 2026. Please find attached the Interim Report H1 2026, now including the Responsibility Statement. No other changes have been made to the report. This information is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading…
Read moreOslo, August 25, 2026 - Observe Medical ASA ("the Company" or "Observe Medical") today publishes its financial report for the first half of 2026. Operating revenues grew 27.4% year-over-year to NOK 14.4 million, driven by increased sales volumes across the UnoMeter™ portfolio, while the gross margin improved to 29.5%. The balance sheet was materially strengthened following the…
Read moreOslo, 29 May 2026 The annual general meeting of Observe Medical ASA (the "Company" or "Observe Medical", Euronext Expand ticker "OBSRV") was held today, on 29 May 2026 at 10:00 hours (CEST), at Dronning Eufemias gate 16, 2nd floor, 0191 Oslo, Norway. All resolutions were made in accordance with the proposals from the board of…
Read more